Raleigh Capital Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-194
Closed -$15.6K 776
2025
Q4
$15.6K Buy
+194
New +$16.2K 0.01% 365
2024
Q1
Sell
-59
Closed -$7.65K 965
2023
Q4
$7.65K Sell
59
-89
-60% -$12.3K ﹤0.01% 656
2023
Q3
$24.1K Buy
148
+48
+48% +$8.44K 0.01% 366
2023
Q2
$18.3K Buy
+100
New +$14.4K 0.01% 400

Other funds holding ACLS

Raleigh Capital Management's ACLS Position: Q1 2026 in Review

Raleigh Capital Management sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 194 shares — an estimated $15.6K sold.

Raleigh Capital Management first reported a position in ACLS in Q2 2023 and held it in 4 quarters. The position peaked at $24.1K in Q3 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Raleigh Capital Management reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Raleigh Capital Management sold 194 Axcelis shares in Q1 2026, an estimated $15.6K.
  • Raleigh Capital Management first reported a position in Axcelis in Q2 2023 and held it in 4 quarters.
  • Raleigh Capital Management's Axcelis position peaked at $24.1K in Q3 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Raleigh Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.